{"id":"peg-3350","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Nausea"},{"rate":"10-20","effect":"Abdominal bloating"},{"rate":"5-15","effect":"Abdominal cramping"},{"rate":"5-10","effect":"Diarrhea"},{"rate":"2-5","effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL1201479","moleculeType":"Small molecule"},"_dailymed":{"setId":"fb3f889c-7f88-4850-9994-d436f9010990","title":"RUGBY PEG 3350 (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [BRYANT RANCH PREPACK]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PEG 3350 (polyethylene glycol 3350) is a non-absorbable polymer that acts as an osmotic agent in the gastrointestinal tract. It remains in the intestinal lumen and pulls water from the bloodstream into the bowel, increasing stool volume and hydration. This softens fecal matter and stimulates peristalsis, facilitating evacuation without systemic absorption or electrolyte disturbances.","oneSentence":"PEG 3350 is an osmotic laxative that draws water into the intestinal lumen to soften stool and promote bowel movements.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:06.230Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Constipation"},{"name":"Bowel preparation prior to colonoscopy or other gastrointestinal procedures"}]},"trialDetails":[{"nctId":"NCT06159777","phase":"PHASE4","title":"Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2024-06-05","conditions":"Constipation, Surgical Procedure, Unspecified, Prolapse; Female","enrollment":74},{"nctId":"NCT02938520","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-27","conditions":"HIV Infections","enrollment":631},{"nctId":"NCT06016387","phase":"PHASE2","title":"Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2023-11-25","conditions":"HER2-positive Breast Cancer, LMD","enrollment":30},{"nctId":"NCT04113382","phase":"PHASE1, PHASE2","title":"Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy","status":"RECRUITING","sponsor":"Ferring Pharmaceuticals","startDate":"2022-06-23","conditions":"Bowel Preparation","enrollment":30},{"nctId":"NCT02951052","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":618},{"nctId":"NCT05424757","phase":"","title":"Polyethylene Glycol Safety in Children","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2022-09-30","conditions":"Polyethylene Glycols, Children, Only","enrollment":158},{"nctId":"NCT05897086","phase":"PHASE2, PHASE3","title":"Polyethylene-glycol Assisted Nerve Repair in Phalloplasty","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2023-08-01","conditions":"Gender Dysphoria","enrollment":30},{"nctId":"NCT07215000","phase":"PHASE4","title":"Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial","status":"RECRUITING","sponsor":"Morehouse School of Medicine","startDate":"2025-10-01","conditions":"Colorectal Cancer Screening, Bowel Cleansing for Colonoscopy","enrollment":300},{"nctId":"NCT05088408","phase":"NA","title":"Comparative Study Between Colonoscopy Bowel Preparation With Clear Liquids, With and Without Two Servings of High Energy Nutritional Supplement","status":"COMPLETED","sponsor":"Clínica de Gastroenterologia","startDate":"2020-10-30","conditions":"Colonoscopy, Bowel Preparation","enrollment":299},{"nctId":"NCT04263896","phase":"PHASE4","title":"Bowel Function After Minimally Invasive Hysterectomy","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2019-08-28","conditions":"Constipation","enrollment":97},{"nctId":"NCT06455813","phase":"PHASE4","title":"What Laxative Should be Used After Hip Fracture Surgery?","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-10-07","conditions":"Hip Fractures","enrollment":375},{"nctId":"NCT04585542","phase":"PHASE4","title":"Comparison of Potassium Binders in the ER","status":"TERMINATED","sponsor":"University of California, Irvine","startDate":"2020-10-20","conditions":"Acute Hyperkalemia, Oral Potassium Binders","enrollment":37},{"nctId":"NCT05821309","phase":"PHASE4","title":"Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-06-08","conditions":"Constipation","enrollment":65},{"nctId":"NCT05805436","phase":"PHASE4","title":"Preop Laxatives in Robotic Urologic Surgery","status":"RECRUITING","sponsor":"Chad R. Tracy","startDate":"2023-06-01","conditions":"Prostate Cancer, Kidney Cancer, Constipation","enrollment":240},{"nctId":"NCT06725888","phase":"NA","title":"Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.","status":"RECRUITING","sponsor":"S.I.I.T. Srl","startDate":"2025-03-31","conditions":"Bacterial Vaginosis (BV), Recurrent Bacterial Vaginosis","enrollment":30},{"nctId":"NCT06825260","phase":"PHASE4","title":"PEG3350 vs Senna After Urogyn Surgery","status":"RECRUITING","sponsor":"St. Joseph's Health, New York","startDate":"2025-04-23","conditions":"Obstructive Defecation Syndrome, Postoperative Constipation","enrollment":254},{"nctId":"NCT06959758","phase":"PHASE4","title":"Effects of Probiotics (BioKid LR - Contains Nine Different Species of Probiotics Bacteria Including L. Reuteri) in Children With Functional Constipation","status":"RECRUITING","sponsor":"Ferass Abu Hanna","startDate":"2024-08-06","conditions":"Constipation","enrollment":80},{"nctId":"NCT04182633","phase":"PHASE2","title":"MTT for Children With ASD Who Have Gastrointestinal Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arizona State University","startDate":"2019-11-15","conditions":"Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation","enrollment":50},{"nctId":"NCT06916689","phase":"NA","title":"Efficacy And Tolerability Of Asymmetric Split Regimen For Bowel Preparation","status":"COMPLETED","sponsor":"ASST Rhodense","startDate":"2023-03-08","conditions":"Colon Preparation, Polyps Colorectal","enrollment":236},{"nctId":"NCT06022302","phase":"NA","title":"Effects of Changing Intestinal Transit Time on Gut Microbial Composition and Metabolism","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2023-10-03","conditions":"Diet, Healthy, Metabolic Disease","enrollment":22},{"nctId":"NCT06836024","phase":"PHASE2, PHASE3","title":"A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-01","conditions":"Constipation - Functional, Constipation, Constipation Aggravated","enrollment":60},{"nctId":"NCT03687814","phase":"NA","title":"Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2018-11-08","conditions":"Irritable Bowel Syndrome Characterized by Constipation","enrollment":78},{"nctId":"NCT06317350","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Gunkang Pharmaceuticals, Inc","startDate":"2024-03-11","conditions":"Colonoscopy, Bowel Preparation","enrollment":318},{"nctId":"NCT03298945","phase":"PHASE4","title":"Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2018-12-13","conditions":"Colorectal Cancer","enrollment":2239},{"nctId":"NCT06393400","phase":"PHASE1","title":"CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)","status":"RECRUITING","sponsor":"John Lenehan","startDate":"2025-01-08","conditions":"Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma","enrollment":20},{"nctId":"NCT04197869","phase":"PHASE4","title":"Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2019-12-09","conditions":"Constipation, Post-Op Complication","enrollment":71},{"nctId":"NCT05896748","phase":"PHASE3","title":"Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2022-11-08","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1)","enrollment":94},{"nctId":"NCT05242562","phase":"NA","title":"Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2022-05-16","conditions":"Colorectal Cancer, Colonic Polyp","enrollment":509},{"nctId":"NCT05436054","phase":"PHASE4","title":"A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy","status":"RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2022-10-01","conditions":"Colon Disease","enrollment":400},{"nctId":"NCT06503978","phase":"PHASE2","title":"Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gut-Brain-Axis Therapeutics Inc.","startDate":"2024-08-20","conditions":"Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation","enrollment":60},{"nctId":"NCT03486821","phase":"NA","title":"Ultra-hypofractionated Radiation in Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2018-03-22","conditions":"Early Stage Prostate Cancer","enrollment":13},{"nctId":"NCT03148002","phase":"PHASE4","title":"Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2017-07-07","conditions":"Constipation, Peritoneal Dialysis Complication","enrollment":25},{"nctId":"NCT04210427","phase":"PHASE4","title":"Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2019-12-12","conditions":"Cystic Fibrosis Gastrointestinal Disease","enrollment":3},{"nctId":"NCT02120352","phase":"PHASE2","title":"A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2014-04-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":309},{"nctId":"NCT05318365","phase":"NA","title":"Bladder and Bowel Dysfunction in Children","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2022-09-01","conditions":"Bladder and Bowel Dysfunction","enrollment":100},{"nctId":"NCT06349031","phase":"PHASE4","title":"Comparison of Efficacy & Tolerability Of PEG 4000 Versus PEG 3350+ Electrolytes for Pediatric Fecal Disimpaction","status":"NOT_YET_RECRUITING","sponsor":"Institute of Medical Sciences and SUM Hospital","startDate":"2024-04-15","conditions":"Functional Constipation, Fecal Impaction, Constipation - Functional","enrollment":100},{"nctId":"NCT05870553","phase":"PHASE3","title":"A Phase 3 Trial in Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Taejoon Pharmaceutical Co., Ltd.","startDate":"2023-01-30","conditions":"Bowel Preparation","enrollment":137},{"nctId":"NCT02765256","phase":"PHASE2","title":"Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2016-08","conditions":"Crohn's Disease","enrollment":8},{"nctId":"NCT01501513","phase":"PHASE3","title":"A Safety Study of 3 Different Bowel Cleansing Preparations","status":"COMPLETED","sponsor":"Braintree Laboratories","startDate":"2011-12","conditions":"Colonoscopy, Bowel Preparation, Endoscopy","enrollment":541},{"nctId":"NCT04270019","phase":"PHASE1, PHASE2","title":"Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration","status":"WITHDRAWN","sponsor":"Nova Scotia Health Authority","startDate":"2020-06-26","conditions":"Peripheral Nerve Injury, Nerve Injury","enrollment":""},{"nctId":"NCT05726344","phase":"NA","title":"Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults","status":"COMPLETED","sponsor":"Hospital de Clínicas Dr. Manuel Quintela","startDate":"2023-02-10","conditions":"Lactulose, Polyethylene Glycol, Bowel Preparation","enrollment":150},{"nctId":"NCT03738904","phase":"PHASE4","title":"Prospective Randomized Controlled Trial of an Enhanced Recovery Protocol for Anorectal Surgery","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-10-26","conditions":"Anorectal Disorder","enrollment":111},{"nctId":"NCT01695863","phase":"PHASE4","title":"Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2012-02","conditions":"Colorectal Cancer","enrollment":150},{"nctId":"NCT02977286","phase":"PHASE4","title":"Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2017-01-01","conditions":"Constipation","enrollment":12},{"nctId":"NCT03216356","phase":"PHASE2, PHASE3","title":"Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD","status":"WITHDRAWN","sponsor":"Boston University Charles River Campus","startDate":"2016-09","conditions":"PTSD","enrollment":""},{"nctId":"NCT04340856","phase":"","title":"Retrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon","status":"COMPLETED","sponsor":"Theresienkrankenhaus und St. Hedwig-Klinik GmbH","startDate":"2020-05-07","conditions":"Megacolon","enrollment":67},{"nctId":"NCT05191810","phase":"NA","title":"Efficacy of Educational Intervention as Supporting Element in the Treatment of Functional Constipation in Children","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2022-03-07","conditions":"Constipation - Functional","enrollment":110},{"nctId":"NCT03476317","phase":"PHASE2","title":"Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-07-12","conditions":"Crohn Disease","enrollment":10},{"nctId":"NCT04380090","phase":"PHASE2","title":"Post-Operative Constipation Following Total Knee Arthroplasty","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2020-02-21","conditions":"Constipation","enrollment":154},{"nctId":"NCT02272868","phase":"PHASE1, PHASE2","title":"Fecal Microbial Transplant in Pediatric Crohn's Disease","status":"TERMINATED","sponsor":"Seattle Children's Hospital","startDate":"2015-01","conditions":"Crohn's Disease","enrollment":7},{"nctId":"NCT02661750","phase":"","title":"Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy","status":"COMPLETED","sponsor":"Gastroenterology Services, Ltd.","startDate":"2016-01","conditions":"Preparation for Colonoscopy","enrollment":79},{"nctId":"NCT01707667","phase":"PHASE4","title":"Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity","status":"COMPLETED","sponsor":"Shire","startDate":"2013-02-27","conditions":"Chronic Constipation","enrollment":13},{"nctId":"NCT04462211","phase":"NA","title":"Constipation Bundle/Protocol and the Effect of Adherence in the Incidence of Constipation in Critically Ill Patients","status":"COMPLETED","sponsor":"University of Chile","startDate":"2019-08-01","conditions":"Constipation, Critical Illness, Constipation Drug Induced","enrollment":66},{"nctId":"NCT02705378","phase":"PHASE3","title":"The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2017-05","conditions":"Constipation, Critical Illness","enrollment":""},{"nctId":"NCT03247595","phase":"NA","title":"Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy","status":"COMPLETED","sponsor":"LifeBridge Health","startDate":"2017-09-26","conditions":"Colonoscopy","enrollment":62},{"nctId":"NCT03198221","phase":"PHASE4","title":"Comparison of Clenpiq vs Golytely Bowel Preparation","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2018-07-11","conditions":"Bowel Preparation Solutions","enrollment":14},{"nctId":"NCT00765557","phase":"EARLY_PHASE1","title":"Randomized, Double-Blinded, Placebo-Controlled Trial of Laxatives for Children With Urge Syndrome","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-12-10","conditions":"Constipation","enrollment":138},{"nctId":"NCT04598880","phase":"PHASE4","title":"Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing","status":"UNKNOWN","sponsor":"Parc de Salut Mar","startDate":"2020-11-06","conditions":"Colonic Diseases","enrollment":1104},{"nctId":"NCT04534465","phase":"PHASE4","title":"Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-02-13","conditions":"Constipation","enrollment":50},{"nctId":"NCT03419806","phase":"PHASE1","title":"Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2018-02-16","conditions":"Parkinson Disease","enrollment":25},{"nctId":"NCT00467350","phase":"NA","title":"Comparison Trial of Enema vs. PEG 3350 for Constipation","status":"TERMINATED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2006-12","conditions":"Constipation","enrollment":80},{"nctId":"NCT03957668","phase":"PHASE3","title":"Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation","status":"UNKNOWN","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2019-12-07","conditions":"Constipation - Functional","enrollment":184},{"nctId":"NCT04588467","phase":"NA","title":"Treatment of Thrombosed Haemorrhoids in Pregnancy","status":"COMPLETED","sponsor":"Russian Society of Colorectal Surgeons","startDate":"2019-01-02","conditions":"Haemorrhoidal Crisis, Pregnancy Related","enrollment":35},{"nctId":"NCT03742232","phase":"PHASE4","title":"Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.","status":"COMPLETED","sponsor":"Istituto Clinico Humanitas","startDate":"2018-10-31","conditions":"Colon Polyp, Colon Adenoma, Colon Lesion","enrollment":399},{"nctId":"NCT03800745","phase":"PHASE4","title":"Reduction of Postoperative Gastrointestinal Dysmotility Following Total Laparoscopic Hysterectomy.","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2018-11-09","conditions":"Postoperative Passage of Flatus, Postoperative Bowel Movement","enrollment":81},{"nctId":"NCT03992365","phase":"PHASE3","title":"Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy","status":"COMPLETED","sponsor":"Universal Integrated Corp.","startDate":"2019-06-10","conditions":"Bowel Preparation","enrollment":472},{"nctId":"NCT04153084","phase":"","title":"Study of Different Endoscopic Preparations Used in Pediatric Colonoscopy","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2018-10-01","conditions":"Digestive Illness","enrollment":126},{"nctId":"NCT04102566","phase":"PHASE4","title":"Optimizing Pain Control in Transurethral Resection of the Prostate","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2017-12-08","conditions":"Pain, BPH With Urinary Obstruction, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms","enrollment":50},{"nctId":"NCT01631435","phase":"PHASE1, PHASE2","title":"PillCam® Platform With the PillCam Crohn's Disease Capsule","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2012-06","conditions":"Crohn's Disease","enrollment":75},{"nctId":"NCT03987893","phase":"PHASE4","title":"PEG3350 in ACLF With Hepatic Encephalopathy","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2018-05-20","conditions":"Hepatic Encephalopathy, Acute-On-Chronic Liver Failure","enrollment":60},{"nctId":"NCT03904303","phase":"PHASE1","title":"Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep","status":"UNKNOWN","sponsor":"Zealand University Hospital","startDate":"2019-06-01","conditions":"Pharmacological Action","enrollment":16},{"nctId":"NCT01841138","phase":"","title":"Changes of Serum Electrolytes During Bowel Prep With PEG 3350 + Ascorbic Acid - a Prospective Study","status":"COMPLETED","sponsor":"Klinik Bogenhausen","startDate":"2010-07","conditions":"Colonoscopy","enrollment":190},{"nctId":"NCT03410524","phase":"PHASE3","title":"Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy","status":"COMPLETED","sponsor":"University of Nevada, Reno","startDate":"2018-01-09","conditions":"Colonoscopy","enrollment":250},{"nctId":"NCT03333070","phase":"NA","title":"The Use of Lactobacillus Reuteri in Functional Constipation in Children","status":"TERMINATED","sponsor":"HaEmek Medical Center, Israel","startDate":"2018-06-26","conditions":"Functional Constipation","enrollment":50},{"nctId":"NCT00770432","phase":"PHASE4","title":"Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-11","conditions":"Constipation","enrollment":203},{"nctId":"NCT03106922","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children","status":"UNKNOWN","sponsor":"Alfasigma S.p.A.","startDate":"2016-04","conditions":"Bowel Preparation Before Colonoscopy","enrollment":430},{"nctId":"NCT02466698","phase":"PHASE2, PHASE3","title":"Intestinal Lavage for the Treatment of Severe C. Difficile Infections","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2016-08","conditions":"Clostridium Difficile","enrollment":20},{"nctId":"NCT02540031","phase":"PHASE3","title":"The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2015-09","conditions":"Bowel Preparation Quality","enrollment":156},{"nctId":"NCT03060512","phase":"PHASE4","title":"To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2017-03-02","conditions":"Opioid Induced Constipation","enrollment":276},{"nctId":"NCT03520361","phase":"PHASE4","title":"Comparison Between OSS and 2L PEG/Asc for Bowel Preparation of Elderly People","status":"UNKNOWN","sponsor":"KangWon National University Hospital","startDate":"2017-11-02","conditions":"Colonoscopy","enrollment":198},{"nctId":"NCT00558376","phase":"NA","title":"Polyethylene Glycol Versus Sodium Phosphate for Colon Preparation After Failure of First Preparation for Colonoscopy","status":"TERMINATED","sponsor":"Sheba Medical Center","startDate":"2008-01","conditions":"Colonoscopy","enrollment":23},{"nctId":"NCT02337413","phase":"PHASE4","title":"Urotherapy vs. Urotherapy With Constipation Treatment for Nocturnal Enuresis","status":"WITHDRAWN","sponsor":"Rabin Medical Center","startDate":"2020-06","conditions":"Nocturnal Enuresis","enrollment":""},{"nctId":"NCT02336906","phase":"PHASE4","title":"Urotherapy vs. Urotherapy With Constipation Treatment for Children With Lower Urinary Tract Dysfunction","status":"WITHDRAWN","sponsor":"Rabin Medical Center","startDate":"2020-01","conditions":"Diurnal Enuresis","enrollment":""},{"nctId":"NCT03332485","phase":"PHASE2","title":"Safety and Efficacy Study of an Edible Colonoscopy Preparation","status":"COMPLETED","sponsor":"Sebela Pharmaceuticals Development LLC","startDate":"2017-11-20","conditions":"Colon Prep for Colonoscopy","enrollment":60},{"nctId":"NCT01745835","phase":"PHASE3","title":"Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2013-01-30","conditions":"Healthy Person, Bowel Preparation Before Colonoscopy","enrollment":196},{"nctId":"NCT02402270","phase":"PHASE2","title":"Safety and Tolerability Study of an Edible Colon Preparation","status":"COMPLETED","sponsor":"ColonaryConcepts LLC","startDate":"2015-05","conditions":"Bowel Preparation","enrollment":69},{"nctId":"NCT01164410","phase":"","title":"The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2009-08","conditions":"Colonoscopy","enrollment":45},{"nctId":"NCT01170754","phase":"PHASE4","title":"Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy","status":"COMPLETED","sponsor":"Temple University","startDate":"2010-04","conditions":"Colon Cancer","enrollment":136},{"nctId":"NCT03279341","phase":"PHASE4","title":"Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Gasthuisberg","startDate":"2012-12-03","conditions":"Chronic Constipation","enrollment":10},{"nctId":"NCT03177434","phase":"PHASE4","title":"Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years.","status":"UNKNOWN","sponsor":"Children's Memorial Health Institute, Poland","startDate":"2016-02","conditions":"Constipation","enrollment":102},{"nctId":"NCT02264249","phase":"","title":"Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2014-09","conditions":"Esophagogastroduodenoscopy, Colonoscopy","enrollment":449},{"nctId":"NCT02102373","phase":"NA","title":"Evaluation of Two Different Diet Regimen Prior to Colonoscopy in Children","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2014-03","conditions":"Children Prior to Colonoscopy","enrollment":184},{"nctId":"NCT00828984","phase":"PHASE2","title":"Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-10","conditions":"Adenomatous Polyp, Colorectal Carcinoma","enrollment":87},{"nctId":"NCT01719653","phase":"PHASE4","title":"A Comparison of 5 Low Volume Bowel Preparations","status":"COMPLETED","sponsor":"Gastroenterology Services, Ltd.","startDate":"2012-10","conditions":"Bowel Preparation for Colonoscopy","enrollment":1079},{"nctId":"NCT01717456","phase":"NA","title":"Educational-Medical-Behavioral Treatment of Fecal Incontinence","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-01","conditions":"Fecal Incontinence","enrollment":31},{"nctId":"NCT01691742","phase":"NA","title":"MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery","status":"COMPLETED","sponsor":"Duke University","startDate":"2012-09","conditions":"Post Procedural Constipation","enrollment":131},{"nctId":"NCT01566409","phase":"NA","title":"Maintenance Treatment for Children With Constipation","status":"COMPLETED","sponsor":"Line Modin","startDate":"2013-09","conditions":"Constipation","enrollment":115},{"nctId":"NCT02073552","phase":"PHASE4","title":"Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid.","status":"COMPLETED","sponsor":"Fundación Canaria Rafael Clavijo para la Investigación Biomédica","startDate":"2014-05","conditions":"Colonoscopy Preparation","enrollment":472},{"nctId":"NCT00626054","phase":"PHASE4","title":"Comparison of Two Methods of Administration of a PEG Solution","status":"COMPLETED","sponsor":"Rabin Medical Center","startDate":"2009-03","conditions":"Colorectal Cancer","enrollment":400},{"nctId":"NCT01212445","phase":"PHASE2","title":"Dose-Finding Trial of Polyethylene Glycol 3350 Laxative Plus Electrolytes for the Treatment of Constipation (Protocol P07515)","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-10","conditions":"Constipation","enrollment":154}],"_emaApprovals":[],"_faersSignals":[{"count":239,"reaction":"VOMITING"},{"count":235,"reaction":"NAUSEA"},{"count":134,"reaction":"ABDOMINAL PAIN"},{"count":128,"reaction":"ABDOMINAL DISTENSION"},{"count":114,"reaction":"PAIN"},{"count":108,"reaction":"DRUG INEFFECTIVE"},{"count":105,"reaction":"HEADACHE"},{"count":99,"reaction":"OFF LABEL USE"},{"count":93,"reaction":"CONSTIPATION"},{"count":85,"reaction":"PYREXIA"}],"_approvalHistory":[{"date":"19991213","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19971210","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20100127","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19970603","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19951102","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20130923","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19930429","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20030807","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20010223","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20000128","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19910422","type":"ORIG","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20210514","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19990325","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19971210","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19961104","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19941118","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20030630","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"19991009","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019797"},{"date":"20211013","type":"SUPPL","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20211013","type":"SUPPL","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20091006","type":"ORIG","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20130206","type":"SUPPL","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20220616","type":"SUPPL","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20191011","type":"SUPPL","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20160112","type":"SUPPL","sponsor":"PPI-DAC","applicationNumber":"ANDA090685"},{"date":"20020919","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19991007","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19970603","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19930324","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19920917","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19920602","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19850419","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20150605","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19840713","type":"ORIG","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20010223","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19990325","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19961104","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19951030","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19930324","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19920820","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19861105","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"19850222","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20160506","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20210514","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20130923","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20200605","type":"SUPPL","sponsor":"AZURITY","applicationNumber":"NDA019011"},{"date":"20181207","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20210514","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20130912","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20080205","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20060802","type":"ORIG","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20220406","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20131217","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20191105","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20120829","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20110428","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20101102","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20081120","type":"SUPPL","sponsor":"SALIX PHARMS","applicationNumber":"NDA021881"},{"date":"20120125","type":"ORIG","sponsor":"NOVEL LABS INC","applicationNumber":"ANDA090145"},{"date":"20120613","type":"SUPPL","sponsor":"NOVEL LABS INC","applicationNumber":"ANDA090145"},{"date":"20191217","type":"SUPPL","sponsor":"NOVEL LABS INC","applicationNumber":"ANDA090145"}],"publicationCount":373,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Miralax","Movicol","MiraLAX or generic equivalent"],"phase":"marketed","status":"active","brandName":"PEG 3350","genericName":"PEG 3350","companyName":"Hamilton Health Sciences Corporation","companyId":"hamilton-health-sciences-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PEG 3350 is an osmotic laxative that draws water into the intestinal lumen to soften stool and promote bowel movements. Used for Constipation, Bowel preparation prior to colonoscopy or other gastrointestinal procedures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}